Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

2 Feb 2023

Abstract excerpt

Acromegaly is a chronic systemic disease caused in the vast majority of cases by growth hormone (GH)-secreting adenoma, with surgery being the first-line treatment. When a cure is not attained with surgery, first-generation somatostatin receptor ligands (fg-SRLs) are the most common medication prescribed. Predictors of response to fg-SRLs have been studied; however, they cannot fully predict the response to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Hedgehog Signaling Pathway Studies
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36769196
DOI: 10.3390/ijms24032875

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in AcromegalyPMID 36769196Read ↗

Treatment of acromegaly in the era of personalized and predictive medicine.Semantic proximity Read ↗

Efficacy and Safety of Pasireotide Treatment in Acromegaly: A Systematic Review and Single Arm Meta-AnalysisSemantic proximity Read ↗

Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify Different Tumoral PhenotypesSemantic proximity Read ↗

Long-term metabolic and biochemical outcomes of pasireotide LAR in resistant acromegalySemantic proximity Read ↗

gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in AcromegalySemantic proximity Read ↗

Differential expression of microRNAs in GH-secreting pituitary adenomas.Semantic proximity Read ↗

Clinical characteristics associated with somatic GNAS mutations in acromegaly: a systematic review and institutional experience.Semantic proximity Read ↗

Genetic Predictors of Response to Different Medical Therapies in Acromegaly.Semantic proximity Read ↗

The Potential Roles of 77C>T Variant and Growth Hormone-Releasing Hormone Elevation in Pituitary Adenoma Cases Associated with AcromegalySemantic proximity Read ↗

Epithelial-Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly.Semantic proximity Read ↗

Consensus on acromegaly complications: an updateSemantic proximity Read ↗

Proteogenomic Landscape and Clinical Characterization of GH-Producing Pituitary AdenomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.